AUDENTES Trademark

Trademark Overview

On Wednesday, October 28, 2020, a trademark application was filed for AUDENTES with the United States Patent and Trademark Office. The USPTO has given the AUDENTES trademark a serial number of 90283917. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 5, 2024. This trademark is owned by Audentes Therapeutics, Inc.. The AUDENTES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for treating genetic diseases and disorders and neuromuscular diseases and disorders; therapeutic pharmaceuticals and substances for treating genetic diseases and disorders and neuromuscular diseases and disorders; pharmaceutical preparations and substances for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of genetic diseases and disorders and neuromuscular diseases and disorders
audentes

General Information

Serial Number90283917
Word MarkAUDENTES
Filing DateWednesday, October 28, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for treating genetic diseases and disorders and neuromuscular diseases and disorders; therapeutic pharmaceuticals and substances for treating genetic diseases and disorders and neuromuscular diseases and disorders; pharmaceutical preparations and substances for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of genetic diseases and disorders and neuromuscular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameASTELLAS GENE THERAPIES, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080
Party NameAudentes Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94108
Party NameAudentes Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94108

Trademark Events

Event DateEvent Description
Sunday, November 1, 2020NEW APPLICATION ENTERED
Monday, December 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 29, 2021ASSIGNED TO EXAMINER
Tuesday, March 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 9, 2021SOU EXTENSION 1 FILED
Tuesday, November 9, 2021SOU EXTENSION 1 GRANTED
Thursday, November 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 30, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 30, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 16, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 16, 2022SOU EXTENSION 2 FILED
Thursday, June 16, 2022SOU EXTENSION 2 GRANTED
Saturday, June 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 20, 2022SOU EXTENSION 3 FILED
Tuesday, December 20, 2022SOU EXTENSION 3 GRANTED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 31, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2023SOU EXTENSION 4 FILED
Wednesday, May 31, 2023SOU EXTENSION 4 GRANTED
Friday, June 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 14, 2023SOU EXTENSION 5 FILED
Monday, January 8, 2024SOU EXTENSION 5 GRANTED
Tuesday, January 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 5, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 5, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

audentes diseases disorders therapy substances preparations pharmaceutical genetic neuromuscular treating cell